Literature DB >> 25232372

The association between B vitamins supplementation and adverse cardiovascular events: a meta-analysis.

Wen-Feng Li1, Dan-Dan Zhang2, Ji-Tian Xia1, Shan-Fan Wen3, Jun Guo1, Zi-Cheng Li1.   

Abstract

This study is to explore the association of adverse cardiovascular events with B vitamins supplementation. Rev.Man 5.1 and Stata 11.0 software were applied for the meta-analysis. The number of cardiovascular events was collected and calculated using indicates of odds ratio and 95% confidence intervals in a fixed-effects or a random-effects model when appropriate. The study includes 15 studies which consists of 37,358 study objects (experimental group: 19,601; control group: 17,757). This study showed that the pooled ORs was 1.01 (95% CI = 0.96~1.06, P > 0.05) for objects with Experimental group (B vitamins supplementation) vs. Control group (placebo or regular treatment), which suggests no significant differences were found in the overall effect of the number of cardiovascular events between the two groups. Further stratification of subgroup analysis indicates no significant differences were found between the two groups as well. There were also no publication bias existing by the Egger's linear regression test (P > 0.05). Our result indicates that the number of cardiovascular events in experimental group using B vitamins supplementation during the treatment is equal to placebo or regular treatment group thus further studies is necessary.

Entities:  

Keywords:  B vitamins supplementation; cardiovascular events; folic acid; meta-analysis

Year:  2014        PMID: 25232372      PMCID: PMC4161532     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

2.  Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry.

Authors:  Carmen Suárez; Uwe Zeymer; Tobias Limbourg; Iris Baumgartner; Patrice Cacoub; Don Poldermans; Joachim Röther; Deepak L Bhatt; Ph Gabriel Steg
Journal:  Vasc Med       Date:  2010-08       Impact factor: 3.239

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

Authors:  Jane M Armitage; Louise Bowman; Robert J Clarke; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Peter Sleight; Richard Peto; Rory Collins
Journal:  JAMA       Date:  2010-06-23       Impact factor: 56.272

5.  Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.

Authors:  Deepak L Bhatt; Kim A Eagle; E Magnus Ohman; Alan T Hirsch; Shinya Goto; Elizabeth M Mahoney; Peter W F Wilson; Mark J Alberts; Ralph D'Agostino; Chiau-Suong Liau; Jean-Louis Mas; Joachim Röther; Sidney C Smith; Geneviève Salette; Charles F Contant; Joseph M Massaro; Ph Gabriel Steg
Journal:  JAMA       Date:  2010-08-30       Impact factor: 56.272

6.  Homocysteine lowering with folic acid and B vitamins in vascular disease.

Authors:  Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey Probstfield; George Fodor; Claes Held; Jacques Genest
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

7.  10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study.

Authors:  Wietske Hermes; Arie Franx; Maria G van Pampus; Kitty W Bloemenkamp; Joris A van der Post; Martina Porath; Gabrielle Ponjee; Jouke T Tamsma; Ben W Mol; Christianne J de Groot
Journal:  BMC Pregnancy Childbirth       Date:  2010-06-01       Impact factor: 3.007

8.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

9.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

Authors:  Christine M Albert; Nancy R Cook; J Michael Gaziano; Elaine Zaharris; Jean MacFadyen; Eleanor Danielson; Julie E Buring; JoAnn E Manson
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

10.  Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.

Authors:  Guido Schnyder; Marco Roffi; Yvonne Flammer; Riccardo Pin; Otto Martin Hess
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272

View more
  4 in total

Review 1.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

Review 2.  Clinical Advances in Immunonutrition and Atherosclerosis: A Review.

Authors:  Ana María Ruiz-León; María Lapuente; Ramon Estruch; Rosa Casas
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

3.  Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease.

Authors:  Monica Verdoia; Matteo Nardin; Rocco Gioscia; Arraa Maddalena Saghir Afifeh; Filippo Viglione; Federica Negro; Marco Marcolongo; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2021-02-04       Impact factor: 2.300

4.  Twelve-Week Daily Consumption of ad hoc Fortified Milk with ω-3, D, and Group B Vitamins Has a Positive Impact on Inflammaging Parameters: A Randomized Cross-Over Trial.

Authors:  Morena Martucci; Maria Conte; Laura Bucci; Enrico Giampieri; Cristina Fabbri; Maria Giustina Palmas; Massimo Izzi; Stefano Salvioli; Angelo Vittorio Zambrini; Carla Orsi; Patrizia Brigidi; Aurelia Santoro; Miriam Capri; Daniela Monti; Claudio Franceschi
Journal:  Nutrients       Date:  2020-11-22       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.